APOS MEDICAL ASSETS LTD. – Trademark Portfolio
Entity Type: 99
APOS MEDICAL ASSETS LTD. holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 9 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 5 Nice Classification classes. Currently, 17 trademarks are registered. Notable registered marks include A, APOS, APOSIQ, APOSCARE, and PERTUPOD.
7 Hapelach St.
6816727 Tel Aviv - Yafo
Showing of trademarks Trademarks
Trademark Classifications
APOS MEDICAL ASSETS LTD.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Education; providing of training; entertainment; sporting and cultural activities
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Frequently Asked Questions
How many trademarks does APOS MEDICAL ASSETS LTD. have?
APOS MEDICAL ASSETS LTD. has 17 U.S. trademarks filed with the USPTO. Of these, 17 registered.
What trademark classes does APOS MEDICAL ASSETS LTD. file in?
APOS MEDICAL ASSETS LTD. files trademarks across 5 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 10 (Medical Apparatus), Class 44 (Medical Services), Class 41 (Education & Entertainment), Class 28 (Toys & Sporting Goods). Class 25 covers clothing, footwear, headgear.
What are APOS MEDICAL ASSETS LTD.'s most well-known trademarks?
APOS MEDICAL ASSETS LTD.'s registered trademark portfolio includes well-known marks such as A, APOS, APOSIQ, APOSCARE, and PERTUPOD. These are among 17 currently registered trademarks in the portfolio.
What is APOS MEDICAL ASSETS LTD.'s trademark registration success rate?
APOS MEDICAL ASSETS LTD. has a 100% trademark registration rate, with 17 out of 17 resolved applications resulting in successful registration. Currently, 0 applications are pending review.